Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06146348 · ClinicalTrials.gov registry record · NA
Deimplementing CXR After CVC (DRAUP) in the ICU
A NA study of Implementation Science and Behavior and Behavior Mechanisms, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06146348: Recruiting NA study of Implementation Science and Behavior and Behavior Mechanisms, sponsored by Washington University School of Medicine.
NCT06146348 is a NA study of Implementation Science and Behavior and Behavior Mechanisms that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 100 participants, below the 1,736-participant average among 13 other Implementation Science trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06146348, a NA study of Implementation Science and Behavior and Behavior Mechanisms, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study proposes adapting and testing an innovative, behavioral theory-driven deimplementation program called DRAUP in two intensive care units for proof of concept and support that the program can help providers and hospital organizations address context determinants of deimplementation. Study data will be used to optimize the intervention for a subsequent larger trials.
Primary Outcome
Deadoption of CXR after US guided CVC confirmation
Conditions Studied
Interventions
- BEHAVIORAL adapted DRAUP strategy bundle
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-01-02 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT06146348 shows while recruiting
NCT06146348 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,736-participant average among 13 other Implementation Science trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Implementation Science appearing as the primary indexed condition, and to 1 intervention - of which adapted DRAUP strategy bundle is the first listed.
NCT06146348 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06146348 about?
NCT06146348 is a clinical study titled "Deimplementing CXR After CVC (DRAUP) in the ICU". This study proposes adapting and testing an innovative, behavioral theory-driven deimplementation program called DRAUP in two intensive care units for proof of concept and support that the program can help providers and hospital organizations address context determinants of deimplementation. Study d...
What is the current status of trial NCT06146348?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-01-02. Estimated completion is 2025-12-31.
What conditions does trial NCT06146348 study?
This clinical trial studies the following conditions: Implementation Science, Behavior and Behavior Mechanisms.
What interventions are being tested in trial NCT06146348?
The interventions under investigation include: adapted DRAUP strategy bundle (BEHAVIORAL).
Who is sponsoring clinical trial NCT06146348?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06146348 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Implementation Science
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06146348's enrollment target sits among peer trials
100 8th of 13 higher than 6 of 13 other Implementation Science trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Implementation Science trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
RECRUITING · NA
-
K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions
RECRUITING · NA
-
Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening
RECRUITING · NA
-
Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers
RECRUITING · NA
-
Implementation Pilot of Preoperative CGA Before Major Surgery
RECRUITING · NA
-
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI